Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Glenmark Pharmaceuticals Inc., USA recalls Propafenone Hydrochloride Extended-Release Capsules USP

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations
Products
  • Propafenone Hydrochloride Extended-Release Capsules USP
Where it was sold

U.S. Nationwide

Nationwide

Units affected
N/A
About this recall
Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-825-01.